Carna Biosciences, Inc.
TSE:4572.T
Overview | Financials
Company Name | Carna Biosciences, Inc. |
Symbol | 4572.T |
Currency | JPY |
Price | 396 |
Market Cap | 7,146,919,296 |
Dividend Yield | 0% |
52-week-range | 285 - 876 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Kohichiro Yoshino Ph.D. |
Website | https://www.carnabio.com |
An error occurred while fetching data.
About Carna Biosciences, Inc.
Carna Biosciences, Inc., a clinical-stage biopharmaceutical company, discovers and develops drug therapies to treat unmet medical needs in Japan. Its products include kinase proteins, substrates, kinase protein assay kits, and stable cell lines, as well as biotinylated kinases to use in the study of kinase-molecule interactions. The company also offers
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD